Group 1 - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for 13 companies, including Mandii International, regarding compliance with offshore structures and reverse mergers [1][2] - Mandii International has submitted its application to the Hong Kong Stock Exchange, with Huatai International as its sole sponsor [1] - The CSRC has requested Mandii International to clarify the compliance of its offshore structure and reverse investment, including foreign exchange management and tax compliance [2] Group 2 - Mandii International is a leading professional consumer pharmaceutical company in China, focusing on skin health and weight management solutions [3] - The company's flagship product, the Mandii® series minoxidil hair loss treatment, has ranked first in the Chinese hair loss medication market for ten consecutive years, with market shares of approximately 57% and 71% in 2024 for the hair loss medication and minoxidil markets, respectively [3]
新股消息 | 蔓迪国际拟港股上市 中国证监会要求补充说明离岸架构及返程并购的合规性等